LTD4

Ltd4 is a lipid of Fatty Acyls (FA) class. Ltd4 is associated with abnormalities such as Inflammatory Bowel Diseases, Inflammatory disorder, Asthma, Pneumonia and Allergic asthma. The involved functions are known as inhibitors, Signal Transduction, Cell Survival, antagonists and Phosphorylation. Ltd4 often locates in Membrane, Tissue membrane, Protoplasm, Cytoplasmic matrix and membrane fraction. The associated genes with LTD4 are ALOX5 gene, UMOD gene, P4HTM gene, RAF1 gene and Homologous Gene. The related lipids are Lipopolysaccharides.

Cross Reference

Introduction

To understand associated biological information of LTD4, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with LTD4?

LTD4 is suspected in Asthma, Inflammatory Bowel Diseases, Inflammatory disorder, Pneumonia, Allergic asthma, Virus Diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with LTD4

MeSH term MeSH ID Detail
Respiratory Hypersensitivity D012130 18 associated lipids
Leukemia, Lymphocytic, Chronic, B-Cell D015451 25 associated lipids
Otitis Media with Effusion D010034 9 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Cough D003371 19 associated lipids
Enteritis D004751 8 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
Carotid Stenosis D016893 15 associated lipids
Influenza, Human D007251 11 associated lipids
Asthma, Exercise-Induced D001250 10 associated lipids
Per page 10 20 50 | Total 39

PubChem Associated disorders and diseases

What pathways are associated with LTD4

Lipid pathways are not clear in current pathway databases. We organized associated pathways with LTD4 through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with LTD4?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with LTD4?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with LTD4?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with LTD4?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with LTD4?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with LTD4

Download all related citations
Per page 10 20 50 100 | Total 640
Authors Title Published Journal PubMed Link
Grönroos E et al. Leukotriene D4 induces a rapid increase in cAMP in the human epithelial cell line, Int 407: a potential role for this signal in the regulation of calcium influx through the plasma membrane. 1998 Cell Calcium pmid:9793684
Jørgensen ST et al. Double mutation at the putative protein kinase C phosphorylation sites Thr151 plus Thr323 in the mouse leukotrieneD4 receptor eliminates homologous desensitization. 2013 Cell. Physiol. Biochem. pmid:23485744
Sakurai S et al. Synthesis and thromboxane A2 antagonistic activity of [[1-aryl(or benzyl)-1-(benzenesulfonamido)methyl]phenyl]alkanoic acid derivatives. 1996 Chem. Pharm. Bull. pmid:8681409
Aida Y et al. The antagonistic effects of khellactones on platelet-activating factor, histamine, and leukotriene D4. 1995 Chem. Pharm. Bull. pmid:7553972
Sakurai S et al. Synthesis and dual antagonistic activity against thromboxane A2 and leukotriene D4 of [4-[1-(benzenesulfonamido)alkyl]phenyl]alkanoic acid derivatives. 1997 Chem. Pharm. Bull. pmid:9178522
Babu KS and Salvi SS Aspirin and asthma. 2000 Chest pmid:11083703
Dayyat E et al. Leukotriene pathways and in vitro adenotonsillar cell proliferation in children with obstructive sleep apnea. 2009 Chest pmid:19118273
Obase Y et al. Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients. 2002 Chest pmid:11796443
Nathan RA et al. Inhaled ICI 204,219 blocks antigen-induced bronchoconstriction in subjects with bronchial asthma. 1994 Chest pmid:8306751
Kanwar S et al. Leukotriene C4/D4 induces P-selectin and sialyl Lewis(x)-dependent alterations in leukocyte kinetics in vivo. 1995 Circ. Res. pmid:7554141
Allen S et al. Differential leukotriene constrictor responses in human atherosclerotic coronary arteries. 1998 Circulation pmid:9641692
Datta YH et al. Peptido-leukotrienes are potent agonists of von Willebrand factor secretion and P-selectin surface expression in human umbilical vein endothelial cells. 1995 Circulation pmid:7586318
Schain F et al. Differential expression of cysteinyl leukotriene receptor 1 and 15-lipoxygenase-1 in non-Hodgkin lymphomas. 2008 Clin Lymphoma Myeloma pmid:19064398
Celik D et al. Cysteinyl leukotrienes in exhaled breath condensate of smoking asthmatics. 2013 Clin. Chem. Lab. Med. pmid:23045385
Mayatepek E et al. Analysis of leukotrienes in cerebrospinal fluid of a reference population and patients with inborn errors of metabolism: further evidence for a pathognomonic profile in LTC(4)-synthesis deficiency. 2000 Clin. Chim. Acta pmid:10686285
Ichiyama T et al. Cysteinyl leukotrienes induce monocyte chemoattractant protein 1 in human monocytes/macrophages. 2005 Clin. Exp. Allergy pmid:16164450
Busse WW et al. Leukotriene pathway inhibitors in asthma and chronic obstructive pulmonary disease. 1999 Clin. Exp. Allergy pmid:10421833
Bossé Y et al. Leukotriene D4-induced, epithelial cell-derived transforming growth factor beta1 in human bronchial smooth muscle cell proliferation. 2008 Clin. Exp. Allergy pmid:18028462
Ichiyama T et al. Pranlukast inhibits NF-kappa B activation in human monocytes/macrophages and T cells. 2003 Clin. Exp. Allergy pmid:12801316
Mechiche H et al. Effects of cysteinyl leukotrienes in small human bronchus and antagonist activity of montelukast and its metabolites. 2003 Clin. Exp. Allergy pmid:12859443
Kurosawa M et al. Inhibition by a novel peptide leukotriene receptor antagonist ONO-1078 of airway wall thickening and airway hyperresponsiveness to histamine induced by leukotriene C4 or leukotriene D4 in guinea-pigs. 1994 Clin. Exp. Allergy pmid:7842366
Shirasaki H et al. Expression and localization of the cysteinyl leukotriene 1 receptor in human nasal mucosa. 2002 Clin. Exp. Allergy pmid:12100046
Heimbürger M and Palmblad JE Effects of leukotriene C4 and D4, histamine and bradykinin on cytosolic calcium concentrations and adhesiveness of endothelial cells and neutrophils. 1996 Clin. Exp. Immunol. pmid:8608646
Joki S and Saano V Influence of ageing on ciliary beat frequency and on ciliary response to leukotriene D4 in guinea-pig tracheal epithelium. 1997 Clin. Exp. Pharmacol. Physiol. pmid:9075591
Ohbayashi H et al. Neutral endopeptidase 3.4.24.11 inhibition potentiates the inhibitory effects of type-C natriuretic peptide on leukotriene D4-induced airway changes. 1998 Clin. Exp. Pharmacol. Physiol. pmid:9887994
Trandafir CC et al. Cysteinyl leukotrienes and leukotriene B mediate vasoconstriction to arginine vasopressin in rat basilar artery. 2005 Clin. Exp. Pharmacol. Physiol. pmid:16445567
Tokuriki S et al. Leukotriene D(4) enhances the function of endothelin-1-primed fibroblasts. 2007 Clin. Immunol. pmid:17627891
Kato J et al. Leukotriene D4 potentiates fibronectin-induced migration of human lung fibroblasts. 2005 Clin. Immunol. pmid:16109507
Smith LJ et al. Inhibition of leukotriene D4-induced bronchoconstriction in subjects with asthma: a concentration-effect study of ICI 204,219. 1993 Clin. Pharmacol. Ther. pmid:8222486
Yang YY et al. Effect of chronic CB1 cannabinoid receptor antagonism on livers of rats with biliary cirrhosis. 2007 Clin. Sci. pmid:17176248
Wooltorton E Asthma drug zafirlukast (Accolate): serious hepatic events. 2004 CMAJ pmid:15159361
Patel JP et al. Beneficial effects of combined thromboxane and leukotriene receptor antagonism in hemorrhagic shock. 1995 Crit. Care Med. pmid:7867347
Guan W et al. Leukotriene D4 bronchial provocation test: methodology and diagnostic value. 2012 Curr Med Res Opin pmid:22435894
Muccitelli RM et al. Cysteinyl leukotriene receptor assays. 2001 Curr Protoc Pharmacol pmid:22293965
Haneda Y et al. Leukotriene D4 enhances tumor necrosis factor-α-induced vascular endothelial growth factor production in human monocytes/macrophages. 2011 Cytokine pmid:21482134
Matsumoto H et al. Interleukin-13 enhanced Ca2+ oscillations in airway smooth muscle cells. 2012 Cytokine pmid:22078634
Spector SL Leukotriene activity modulation in asthma. 1997 Drugs pmid:9279501
Khayyal MT et al. Mechanisms involved in the antiinflammatory effect of propolis extract. 1993 Drugs Exp Clin Res pmid:7513636
Marusova IB et al. [Potential gastroprotective effect of a CysLT1 receptor blocker sodium montelukast in aspirin-induced lesions of the rat stomach mucosa]. 2002 May-Jun Eksp Klin Farmakol pmid:12227087
Traianedes K et al. 5-Lipoxygenase metabolites inhibit bone formation in vitro. 1998 Endocrinology pmid:9645691
Hazel BA et al. Induction of granulocytic differentiation in a mouse model by benzene and hydroquinone. 1996 Environ. Health Perspect. pmid:9118902
Ballart B et al. Synthesis and pharmacological evaluation of new 4-2-(7-heterocyclemethoxynaftalen-2-ylmethoxy)ethylbenzoic acids as LTD(4)-antagonists. 2000 Eur J Med Chem pmid:10858604
Thioudellet C et al. Molecular and functional characterization of recombinant human gamma-glutamyltransferase. Coupling of its activity to glutathione levels in V79 cells. 1994 Eur. J. Biochem. pmid:7913033
Lankisch TO et al. High-affinity cholecystokinin type A receptor/cytosolic phospholipase A2 pathways mediate Ca2+ oscillations via a positive feedback regulation by calmodulin kinase in pancreatic acini. 1999 Eur. J. Cell Biol. pmid:10535305
Massoumi R and Sjölander A The inflammatory mediator leukotriene D4 triggers a rapid reorganisation of the actin cytoskeleton in human intestinal epithelial cells. 1998 Eur. J. Cell Biol. pmid:9716265
Ibe BO et al. Plasma and urinary leukotrienes in sickle cell disease: possible role in the inflammatory process. 1994 Eur. J. Clin. Invest. pmid:8187808
Dahlén B et al. Salbutamol but not ipratropium abolishes leukotriene D4-induced gas exchange abnormalities in asthma. 2012 Eur. J. Clin. Pharmacol. pmid:22457014
Brocks DR et al. The single and multiple dose pharmacokinetics of pranlukast in healthy volunteers. 1996 Eur. J. Clin. Pharmacol. pmid:9010703
Wensing G et al. Effect of BAY x 7195, an oral receptor antagonist of cysteinyl-leukotrienes, on leukotriene D4-induced bronchoconstriction in normal volunteers. 1994 Eur. J. Clin. Pharmacol. pmid:7867675
Przylipiak A et al. Influence of leukotrienes on in vitro growth of human mammary carcinoma cell line MCF-7. 1998 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:9550202